Cargando…
Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide
BACKGROUND: A cohort study was performed to identify ovarian reserve markers (ORM) that predicts amenorrhea or oligomenorrhea 6 months after cyclophosphamide CTX in women with breast cancer. METHODS: 52 eumenorrheic patients with breast cancer were enrolled. FSH, anti-Müllerian hormone (AMH), antral...
Autores principales: | D’Avila, Ângela Marcon, Biolchi, Vanderlei, Capp, Edison, Corleta, Helena von Eye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678664/ https://www.ncbi.nlm.nih.gov/pubmed/26667243 http://dx.doi.org/10.1186/s13048-015-0209-4 |
Ejemplares similares
-
Antral Follicles Count and Anti-Müllerian Hormone Levels after Gonadotoxic Chemotherapy in Patients with Breast Cancer: Cohort Study
por: D'Avila, Ângela Marcon, et al.
Publicado: (2017) -
Serum Anti-Müllerian Hormone Is an Effective Indicator of Antral Follicle Counts but Not Primordial Follicle Counts
por: Zhou, Yiran, et al.
Publicado: (2023) -
Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve
por: Panchal, Sonal, et al.
Publicado: (2012) -
Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction
por: Himabindu, Y, et al.
Publicado: (2013) -
The Correlations of Anti-Mullerian Hormone,
Follicle-Stimulating Hormone and Antral
Follicle Count in Different Age Groups
of Infertile Women
por: Barbakadze, Ludmila, et al.
Publicado: (2015)